The long-term retention of pregabalin in a large cohort of patients with epilepsy at a tertiary referral centre

Epilepsy Research

Volumn 87, Issue 2-3, 2009, Pages 120-123

  Yuen, Alan W C ^a   Singh, Rinki ^a   Bell, Gail S ^a   Bhattacharjee, Anupam ^a   Neligan, Aidan ^a   Heaney, Dominic C ^a   Duncan, John S ^a   Sander, Josemir W ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

Epilepsy; Long term retention; Pregabalin

Indexed keywords

PREGABALIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ATAXIA; BLURRED VISION; CENTRAL NERVOUS SYSTEM DISEASE; COHORT ANALYSIS; DEPRESSION; DIPLOPIA; DISEASE EXACERBATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; ENDOCRINE DISEASE; EPILEPSY; FATIGUE; FEMALE; FOCAL EPILEPSY; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GRAND MAL SEIZURE; HUMAN; INFECTION; LETHARGY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL DISEASE; MOOD; PRIORITY JOURNAL; SEX DIFFERENCE; SIDE EFFECT; SKIN DISEASE; UNSTEADINESS; URINARY TRACT DISEASE; WEIGHT GAIN;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CHI-SQUARE DISTRIBUTION; EPILEPSY; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MEDICAL RECORDS; MIDDLE AGED; PATIENT SATISFACTION; REGRESSION ANALYSIS; SEX FACTORS; TREATMENT OUTCOME;

EID: 70449651972     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2009.08.001     Document Type: Article

References (14)

1. Arroyo S., Anhut H., Kugler A.R., Lee C.M., Knapp L.E., Garofalo E.A., and Messmer S. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 45 (2004) 20-27
2. Ben-Menachem E. Weight issues for people with epilepsy-a review. Epilepsia 48 Suppl. 9 (2007) 42-45
3. Beydoun A., Uthman B.M., Kugler A.R., Greiner M.J., Knapp L.E., and Garofalo E.A. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 64 (2005) 475-480
4. Carreno M., Maestro I., Molins A., Donaire A., Falip M., Becerra J.L., and Castillo J. Pregabalin as add-on therapy for refractory partial seizures in every day clinical practice. Seizure 16 (2007) 709-712
5. Cox D. Regression models and life tables. J. R. Stat. Soc. 34 (1972) 187-220
6. Depondt C., Yuen A.W., Bell G.S., Mitchell T., Koepp M.J., Duncan J.S., and Sander J.W. The long term retention of levetiracetam in a large cohort of patients with epilepsy. J. Neurol. Neurosurg. Psychiatry 77 (2006) 101-103
7. Elger C.E., Brodie M.J., Anhut H., Lee C.M., and Barrett J.A. Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study. Epilepsia 46 (2005) 1926-1936
8. French J.A., Kugler A.R., Robbins J.L., Knapp L.E., and Garofalo E.A. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 60 (2003) 1631-1637
9. Hamandi K., and Sander J.W. Pregabalin: a new antiepileptic drug for refractory epilepsy. Seizure 15 (2006) 73-78
10. Huber B., Bocchicchio M., Feuerbaum E., May T., Meinert T., Robertson E., Schorlemmer H., Wagner W., Wilking E., and Seidel M. Efficacy and tolerability of pregabalin in patients with difficult-to-treat epilepsy and intellectual disability. Epilepsy Behav. 13 (2008) 397-401
11. Kaplan E., and Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53 (1958) 457-481
12. Lhatoo S.D., Wong I.C., Polizzi G., and Sander J.W. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy. Epilepsia 41 (2000) 1592-1596
13. Lozsadi D., Hemming K., and Marson A.G. Pregabalin add-on for drug-resistant partial epilepsy. Cochrane Database Syst. Rev. (2008) CD005612
14. Mula M., and Sander J.W. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf. 30 (2007) 555-567